- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 233/22 - Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
Patent holdings for IPC class C07C 233/22
Total number of patents in this class: 68
10-year publication summary
5
|
3
|
1
|
4
|
6
|
6
|
4
|
3
|
4
|
1
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Novaremed Limited | 11 |
5 |
Atnx Spv, LLC | 38 |
3 |
Rohm and Haas Company | 2895 |
2 |
Dow Global Technologies LLC | 10315 |
2 |
Athenex, Inc. | 27 |
2 |
Firmenich SA | 1676 |
2 |
Les Laboratoires Servier | 538 |
2 |
Rohm and Haas Electronic Materials LLC | 168 |
2 |
Axichem AS | 2 |
2 |
Bristol-myers Squibb Company | 4897 |
1 |
F. Hoffmann-La Roche AG | 7908 |
1 |
The Regents of the University of California | 19780 |
1 |
AstraZeneca AB | 2933 |
1 |
FUJIFILM Corporation | 29172 |
1 |
Takeda Pharmaceutical Company Limited | 2703 |
1 |
Al-Quds University | 4 |
1 |
AMPLA Pharmaceuticals Inc. | 10 |
1 |
Arena Pharmaceuticals, Inc. | 367 |
1 |
Cellix Bio Private Limited | 51 |
1 |
Centre for Drug Research and Development | 20 |
1 |
Other owners | 35 |